Innovative Research Organization to Facilitate Clinical Trials Implementation in the Era of Molecular Oncology: The Spiderweb Model of the Oncodistinct Network.
AuteursNannini S, Goncalves A, Gomez-Roca C, Papamichael D, El Idrissi I, Awada A, Kotecki N
The dual gap ionization chamber: a novel ionization chamber design for reference dosimetry to automatically correct for recombination losses in emerging radiotherapy modalities.
AuteursOrts M, Rossomme S, Souris K, de Beco V, Haas T, Durny N, Houyoux GG, Penninckx S, Verpoest L, Vanreusel V, Montay-Gruel PG, Kuess P, Palmans H, Sterpin E
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial.
AuteursZilli T, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Iturre AV, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C, Achard V, Stellamans K, Goetghebeur E, Reynders D, Ost P
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies.
AuteursNardin S, Bruzzone M, Arecco L, Chiappe E, Lanzavecchia C, Ruelle T, Giannubilo I, Razeti MG, Borea R, Barcellini L, Bruzzone F, Daneri A, Molinelli C, Soldato D, Levaggi A, Bighin C, Barbero V, Ottonello S, Scavone G, Fregatti P, Spinaci S, Cardinali B, Tagliamento M, Blondeaux E, Lambertini M, Del Mastro L, Poggio F
Validation of PREDICT tool v2.2 in patients with early-stage breast cancer enrolled in the GIM and MIG trials.
AuteursBorea R, Blondeaux E, Carmisciano L, Arecco L, Perachino M, Poggio F, Ruelle T, Luelli F, de Laurentiis M, Arpino G, Puglisi F, Fabi A, Gori S, Fregatti P, Lambertini M, Boni L, Del Mastro L
